Profound Medical Corp. (PROF) Social Stream
PROFOUND MEDICAL CORP (PROF) Price Targets From Analysts
Use the tables below to see what analysts covering PROFOUND MEDICAL CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 4 | $30 | $26.25 | $28.062 | $14.11 | 98.88% |
| 2022-01-18 | 4 | $30.001 | $26.25 | $28.062 | $14.11 | 98.88% |
| 2022-03-04 | 4 | $30.001 | $23 | $26.812 | $14.11 | 90.02% |
| 2022-03-08 | 4 | $26.25 | $14 | $21.562 | $14.11 | 52.81% |
| 2022-03-18 | 4 | $26.25 | $14 | $21.312 | $14.11 | 51.04% |
| 2022-05-09 | 4 | $26.25 | $14 | $20.562 | $14.11 | 45.73% |
| 2022-05-10 | 4 | $22 | $14 | $17.5 | $14.11 | 24.03% |
| 2022-05-23 | 4 | $22 | $12 | $16.4 | $14.11 | 16.23% |
| 2022-07-18 | 4 | $20 | $12 | $15.5 | $14.11 | 9.85% |
| 2022-08-05 | 4 | $18 | $12 | $15.1 | $14.11 | 7.02% |
| 2022-09-28 | 4 | $18 | $12 | $14.6 | $14.11 | 3.47% |
| 2022-11-03 | 4 | $18 | $12 | $14.6 | $14.11 | 3.47% |
| 2022-11-07 | 4 | $15 | $6.5 | $12.375 | $14.11 | -12.3% |
| 2022-11-08 | 4 | $15 | $5.5 | $11 | $14.11 | -22.04% |
| 2023-01-06 | 3 | $15 | $5.5 | $11.5 | $14.11 | -18.5% |
| 2023-03-08 | 3 | $17 | $5.5 | $11.833 | $14.11 | -16.14% |
| 2023-03-21 | 3 | $17 | $6.5 | $12.583 | $14.11 | -10.82% |
| 2023-05-10 | 4 | $17 | $6.5 | $12.583 | $14.11 | -10.82% |
| 2023-05-15 | 4 | $18 | $6.5 | $13.5 | $14.11 | -4.32% |
| 2023-06-05 | 4 | $20 | $6.5 | $14.666 | $14.11 | 3.94% |
The Trend in the Analyst Price Target
Over the past 31 months, PROF's average price target has gone down $8.62.
Over the past 46 weeks, PROF's average upside potential has been 85.76%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-06 | 4 | 18 | 12.0 | 14.600 | 5.60 | 160.71% |
| 2022-11-03 | 4 | 18 | 12.0 | 14.600 | 3.92 | 272.45% |
| 2022-11-08 | 4 | 15 | 5.5 | 11.000 | 4.85 | 126.8% |
| 2023-01-06 | 3 | 15 | 5.5 | 11.500 | 11.62 | -1.03% |
| 2023-06-05 | 4 | 20 | 6.5 | 14.666 | 13.66 | 7.36% |
PROF Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
PROF's average broker recommendation rating worsened by 0.25 over the prior 48 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PROF has a higher number of analysts covering the stock than 282.49% of all US stocks.
- In terms of how PROFOUND MEDICAL CORP fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 612.79% of that group.
- In the context of all US stocks, PROFOUND MEDICAL CORP's average analyst price target is higher than 411.09% of them.
- To contextualize these metrics, consider that out of Medical Equipment stocks, PROFOUND MEDICAL CORP's variance in analysts' estimates is lower than -1255.16% of them.
In the Medical Equipment industry, RCEL, XAIR, and LQDA are the three stocks most similar to PROFOUND MEDICAL CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PROF a Buy, Hold or Sell? See the POWR Ratings now!